430 related articles for article (PubMed ID: 26290123)
21. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
[TBL] [Abstract][Full Text] [Related]
22. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
Horton LG; Simmons KB; Curtis KM
Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
[TBL] [Abstract][Full Text] [Related]
23. [Oral contraceptive pill and thrombotic risk: epidemiological studies].
Fruzzetti F; Perini D; Spirito N; Manca R
Minerva Ginecol; 2012 Dec; 64(6):539-49. PubMed ID: 23232538
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for superficial vein thrombosis in patients with primary chronic venous disease.
Musil D; Kaletova M; Herman J
Vasa; 2016 Jan; 45(1):63-6. PubMed ID: 26986712
[TBL] [Abstract][Full Text] [Related]
25. Progestin-only contraception and venous thromboembolism.
Blanco-Molina MA; Lozano M; Cano A; Cristobal I; Pallardo LP; Lete I
Thromb Res; 2012 May; 129(5):e257-62. PubMed ID: 22425318
[TBL] [Abstract][Full Text] [Related]
26. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
27. Association between red cell distribution width and risk of venous thromboembolism.
Bucciarelli P; Maino A; Felicetta I; Abbattista M; Passamonti SM; Artoni A; Martinelli I
Thromb Res; 2015 Sep; 136(3):590-4. PubMed ID: 26220270
[TBL] [Abstract][Full Text] [Related]
28. Inherited risk factors in low-risk venous thromboembolism in patients under 45 years.
Yilmaz S; Gunaydin S
Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):21-3. PubMed ID: 25326427
[TBL] [Abstract][Full Text] [Related]
29. Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study.
Martinelli I; Maino A; Abbattista M; Bucciarelli P; Passamonti SM; Artoni A; Gianniello F; Peyvandi F
Thromb Res; 2016 May; 141():153-7. PubMed ID: 27043069
[TBL] [Abstract][Full Text] [Related]
30. Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry.
Blanco-Molina A; Trujillo-Santos J; Tirado R; Cañas I; Riera A; Valdés M; Monreal M;
Thromb Haemost; 2009 Mar; 101(3):478-82. PubMed ID: 19277408
[TBL] [Abstract][Full Text] [Related]
31. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism does not share strong familial susceptibility with pre-eclampsia/eclampsia: a nationwide family study in Sweden.
Zöller B; Li X; Sundquist J; Sundquist K
BJOG; 2013 Sep; 120(10):1200-6. PubMed ID: 23906308
[TBL] [Abstract][Full Text] [Related]
33. Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia.
Wichers IM; Tanck MW; Meijers JC; Lisman T; Reitsma PH; Rosendaal FR; Büller HR; Middeldorp S
Thromb Haemost; 2009 Mar; 101(3):465-70. PubMed ID: 19277406
[TBL] [Abstract][Full Text] [Related]
34. Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene.
Santamaría A; Mateo J; Oliver A; Menéndez B; Souto JC; Borrell M; Soria JM; Tirado I; Fontcuberta J
Haematologica; 2001 Sep; 86(9):965-71. PubMed ID: 11532625
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives.
Vaillant-Roussel H; Ouchchane L; Dauphin C; Philippe P; Ruivard M
Contraception; 2011 Nov; 84(5):e23-30. PubMed ID: 22018134
[TBL] [Abstract][Full Text] [Related]
36. Contraception-related venous thromboembolism in adolescents.
O'Brien SH
Semin Thromb Hemost; 2014 Feb; 40(1):66-71. PubMed ID: 24356931
[TBL] [Abstract][Full Text] [Related]
37. [Risk factors for thromboembolic disease in young women-the role of hormones].
Tromeur C; Le Mao R; Jego P; El-Kouri D; Gruel Y; Pan-Petesch B; Bertoletti L; Morange PE; Lemoigne E; Paleiron N; Leroyer C; Couturaud F
Rev Mal Respir; 2019 Feb; 36(2):219-226. PubMed ID: 30318429
[TBL] [Abstract][Full Text] [Related]
38. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
van Vlijmen EF; Brouwer JL; Veeger NJ; Eskes TK; de Graeff PA; van der Meer J
Arch Intern Med; 2007 Feb; 167(3):282-9. PubMed ID: 17296885
[TBL] [Abstract][Full Text] [Related]
39. Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden.
Zöller B; Ohlsson H; Sundquist J; Sundquist K
Thromb Haemost; 2013 Mar; 109(3):458-63. PubMed ID: 23348971
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors for Venous Thromboembolism Among Reproductive Age Women.
Westhoff CL; Yoon LS; Tang R; Pulido V; Eisenberger A
J Womens Health (Larchmt); 2016 Jan; 25(1):63-70. PubMed ID: 26317174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
